The urine proteome as a radiation biodosimeter

Advances in Experimental Medicine and Biology

Volumn 990, Issue , 2013, Pages 87-100

  Sharma, Mukut ^a   Moulder, John E ^b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

Biomarkers; Dosimetry; Ionizing radiation; Kidney; Plasma; Plasma proteins; Proteinase inhibitors; Proteinases; Proteome; Radiological terrorism; Renal; Triage

Indexed keywords

ACUTE PHASE PROTEIN; ALBUMIN; AMINO ACID; CHYMOTRYPSIN; CREATININE; CYSTATIN; ENZYME PRECURSOR; HISTIDINE; KALLIKREIN 1 RELATED PEPTIDASE B24; OROSOMUCOID; PEPTIDASE; PLASMA PROTEIN; PROTEINASE; PROTEINASE INHIBITOR; PROTEOME; UNCLASSIFIED DRUG; URINE PROTEOME; BIOLOGICAL MARKER;

ACCIDENT; ACUTE KIDNEY FAILURE; ARTICLE; CREATININE URINE LEVEL; DEMOGRAPHY; DOSIMETER; HUMAN; IONIZING RADIATION; KIDNEY FUNCTION; KIDNEY STRUCTURE; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; NEPHRON; NONHUMAN; OXIDATION; PARTIAL BODY RADIATION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN URINE LEVEL; PROTEOMICS; RADIATION BIODOSIMETER; RADIATION EXPOSURE; RADIATION HAZARD; RADIATION RESPONSE; RADIOSENSITIVITY; TERRORISM; VICTIM; WHOLE BODY RADIATION; X RAY; ANIMAL; ENVIRONMENTAL EXPOSURE; KIDNEY; METABOLISM; METHODOLOGY; ORGANS AT RISK; PATHOLOGY; RADIATION INJURY; RADIOMETRY; RAT; REVIEW; SELF EVALUATION; TANDEM MASS SPECTROMETRY; URINE;

ANIMALS; BIOLOGICAL MARKERS; DIAGNOSTIC SELF EVALUATION; ENVIRONMENTAL EXPOSURE; HUMANS; KIDNEY; ORGANS AT RISK; PROTEOME; PROTEOMICS; RADIATION INJURIES; RADIATION, IONIZING; RADIOMETRY; RATS; TANDEM MASS SPECTROMETRY; TERRORISM; WHOLE-BODY IRRADIATION;

MLCS; MLOWN;

EID: 84934442852     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-94-7-5896-4_5     Document Type: Article

References (80)

1. National Research Council (2009) Assessing medical preparedness to respond to a terrorist nuclear event: workshop report. The National Academy Press, Washington, DC
2. Sarin R (2011) Chernobyl, Fukushima, and beyond: a health safety perspective. J Cancer Res Ther 7(2):109-111
3. National Council on Radiation Protection and Measurements (2001) Management of terrorist events involving radioactive material. NCRP report no. 138, Bethesda
4. Swartz HM, Flood AB, Gougelet RM, Rea ME, Nicolalde RJ, Williams BB (2010) A critical assessment of biodosimetry methods for large-scale incidents. Health Phys 98(2):95-108
5. Lenarczyk M, Cohen EP, Fish BL, Irving AA, Sharma M, Driscoll CD et al (2009) Chronic oxidative stress as a mechanism for radiation nephropathy. Radiat Res 171(2):164-172
6. Moulder JE, Cohen EP, Fish BL (2011) Captopril and losartan for mitigation of renal injury caused by single-dose total body irradiation. Radiat Res 175(1):29-36
7. Baker JE, Fish BL, Su J, Haworth ST, Strande JL, Komorowski RA et al (2009) 10 Gy total body irradiation increases risk of coronary sclerosis, degeneration of heart structure and function in a rat model. Int J Radiat Biol 85(12):1089-1100
8. Moulder JE, Fish BL, Holcenberg JS, Sun GX (1990) Hepatic function and drug pharmacokinetics after total body irradiation plus bone marrow transplant. Int J Radiat Oncol Biol Phys 19:1389-1396
9. Rosenthal RA, Fish B, Hill RP, Huffman KD, Lazarova Z, Mahmoud J et al (2011) Salen Mn complexes mitigate radiation injury in normal tissues. Anti-Cancer Agents Med Chem 11(4): 359-371
10. McCarthy ET, Sharma R, Sharma M (2005) Protective effect of 20-hydroxy-eicosatetraenoic acid (20-HETE) on glomerular protein permeability barrier. Kidney Int 67(1):152-156
11. Dahly-Vernon AJ, Sharma M, McCarthy ET, Savin VJ, Ledbetter SR, Roman RJ (2005) Transforming growth factor-", 20-HETE interaction, and glomerular injury in Dahl Salt-Sensitive rats. Hypetension 45:1-6
12. Sharma R, Sharma M, Reddy S, Savin VJ, Nagaria AM, Wiegmann TB (2006) Chronically increased intrarenal angiotensin II causes nephropathy in an animal model of type 2 diabetes. Front Biosci 1(11):968-976
13. Sharma M, Sharma R, Reddy SR, McCarthy ET, Savin VJ (2002) Proteinuria after injection of human focal segmental glomerulosclerosis factor. Transplantation 73:366-372
14. Sharma M, Sharma R, McCarthy ET, Savin VJ (2004) The FSGS permeability factor: biochemical characteristics and biological effects. Exp Biol Med 229:85-98
15. Sharma M, Sharma R, Ge XL, Fish BL, McCarthy ET, Savin VJ, Cohen EP, Moulder JE (2001) Early detection of radiation-induced glomerular injury by albumin permeability assay. Radiat Res 155:474-480
16. Sharma M, Halligan BD, Wakim BT, Savin VJ, Cohen EP, Moulder JE (2008) The urine proteome as a biomarker of radiation injury. Proteomics Clin Appl 2(7):1065-1086
17. Yammani RR, Sharma M, Seetharam S, Moulder JE, Seetharam B (2002) Loss of albumin and megalin binding to renal cubilin results in albuminuria in rats exposed to total body irradiation. Am J Physiol Regul Integr Comp Physiol 283(2):R339-R346
18. Rose BD (1987) Pathophysiology of renal disease. McGraw-Hill Professional, New York, pp 366-368
19. Prasanna PGS, Blakely WF, Bertho JM, Chute JP, Cohen EP, Goans RE et al (2010) Synopsis of partialbody radiation diagnostic biomarkers and medical management of radiation injury workshop. Radiat Res 173(2):245-253
20. Savin VJ, McCarthy ET, Sharma M (2012) Permeability factors in nephrotic syndrome and focal segmental glomerulosclerosis. Kidney Res Clin Pract 31:205-213
21. Rojas-Palma C, Liland A, Jerstad AN, Etherington G, del Rosario Pérez M, Rahola T et al (2009) TMT HANDBOOKtriage, monitoring and treatment handbook for management of the public in the event of malevolent use of radiation. Norwegian Radiation Protection Agency, Østerås
22. Swartz HM, Williams BB, Nicolade RJ, Demidenko E, Flood AB (2011) Overview of biodosimetry for management of unplanned exposures to ionizing radiation. Radiat Meas 46:742-748
23. Demidenko E, Williams BB, Swartz HM (2009) Radiation dose prediction using data on time to emesis in the case of nuclear terrorism. Radiat Res 171(3):310-319
24. IAEA (2001) Cytogenetic analysis for radiation dose assessment: a manual. Technical report 405, IAEA, Vienna
25. ISO (2004) Radiation protectionperformance criteria for service laboratories performing biological dosimetry by cytogenetics. ISO 19238:2004, International Organization for Standardization, Geneva
26. Garty G, Karam A, Brenner DJ (2011) Infrastructure to support ultra high throughput biodosimetry screening after a radiological event. Int J Radiat Biol 87:754-765
27. IAEA (2002) Use of electron paramagnetic resonance dosimetry with tooth enamel for retrospective dose assessment. TECDOC-1331, IAEA. Vienna
28. Swartz HM, Burke G, Coey M, Demidenko E, Dong R, Grinberg O, Hilton J, Iwasaki A, Lesniewski P, Schauer DA (2007) In vivo EPR for dosimetry. Radiat Meas 42:1075-1084
29. Trompier F, Kornak L, Calas C, Romanyukha A, Leblanc B, Mitchell CA, Swartz HM, Clairand I (2007) Protocol for emergency EPR dosimetry in fingernails. Radiat Meas 42:1085-1088
30. Godfrey-Smith DI, Pass B (1997) A new method for retrospective radiation dosimetry: optically stimulated luminescence in dental enamel. Health Phys 72:744-749
31. Blakely WF, Prasanna PG, Grace MB, Miller AC (2001) Radiation exposure assessment using cytological and molecular biomarkers. Radiat Prot Dosimetry 97(1):17-23
32. Meadows SK, Dressman HK, Muramoto GG, Himburg H, Salter A, Wei Z, Ginsburg G, Chao NJ, Nevins JR, Chute JP (2008) Gene expression signatures of radiation response are specific, durable and accurate in mice and humans. PLoS One 3:e1912
33. Kabacik S, Mackay A, Tamber N, Manning G, Finnon P, Paillier F, Ashworth A, Bouffler S, Badie C (2011) Gene expression following ionising radiation: identification of biomarkers for dose estimation and prediction of individual response. Int J Radiat Biol 87(2):115-129
34. Lewis BP, Burge CB, Bartel DP (2005) Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 120:15-20
35. Marsit CJ, Eddy K, Kelsey KT (2006) MicroRNA responses to cellular stress. Cancer Res 66:10843-10848
36. Cha HJ, Seong KM, Bae S, Jung JH, Kim CS, Yang KH, Jin YW, An S (2009) Identification of specific microRNAs responding to low and high dose gammairradiation in the human lymphoblast line IM9. Oncol Rep 22(4):863-868
37. Coy SL, Cheema AK, Tyburski JB, Laiakis EC, Collins SP, Fornace A Jr (2011) Radiation metabolomics and its potential in biodosimetry. Int J Radiat Biol 87(8):802-823
38. Chen C, Brenner DJ, Brown TR (2011) Identification of urinary biomarkers from X-irradiated mice using NMR spectroscopy. Radiat Res 175(5): 622-630
39. Johnson CH, Patterson AD, Krausz KW, Lanz C, Kang DW, Luecke H, Gonzalez FJ, Idle JR (2011) Radiation metabolomics. 4. UPLC-ESI-QTOFMSBased metabolomics for urinary biomarker discovery in gamma-irradiated rats. Radiat Res 175(4): 473-484
40. Kortz L, Helmschrodt C, Ceglarek U (2011) Fast liquid chromatography combined with mass spectrometry for the analysis of metabolites and proteins in human body fluids. Anal Bioanal Chem 399:2635-2644
41. Zerefos PG, Aivaliotis M, Baumann M, Vlahou A (2012) Analysis of the urine proteome via a combination of multi-dimensional approaches. Proteomics European Consortium. doi:10.1002/pmic.201100212
42. Thongboonkerd V (2007) Practical points in urinary proteomics. J Proteome Res 6(10):3881-3890
43. Apweiler R, Aslanidis C, Deufel T, Gerstner A et al (2009) Approaching clinical proteomics: current state and future fields of application in fluid proteomics. Clin Chem Lab Med 47(6):724-744
44. Court M, Selevsek N, Matondo M, Allory Y, Garin J, Masselon CD, Domon B (2011) Toward a standardized urine proteome analysis methodology. Proteomics 11(6):1160-1171
45. Mirza SP, Olivier M (2008) Methods and approaches for the comprehensive characterization and quantification of cellular proteomes using mass spectrometry. Physiol Genomics 33:3-11
46. Calligaris D, Villard C, Lafitte D (2011) Advances in top-down proteomics for disease biomarker discovery. J Proteomics 74(7):920-934
47. Halligan BD, Greene AS (2011) Visualize: a free and open source multifunction tool for proteomics data analysis. Proteomics 11(6):1058-1063
48. Wu B, Guan Z, Zhao H (2006) Parametric and nonparametric FDR estimation revisited. Biometrics 62:735-744
49. Ashburner M, Ball CA, Blake JA, Botstein D et al (2000) Gene ontology: tool for the unification of biology. The Gene Ontology Consortium. Nat Genet 25:25-29
50. Harris MA, Clark J, Ireland A, Lomax J et al (2004) The Gene Ontology (GO) database and informatics resource. Nucleic Acids Res 32(Database issue):D258-D261
51. Pan S, Aebersold R, Chen R, Rush J, Goodlett DR, McIntosh MW, Zhang J, Brentnall TA (2009) Mass spectrometry based targeted protein quantification: methods and applications. J Proteome Res 8(2): 787-797
52. Brewis IA, Brennan P (2010) Proteomics technologies for the global identification and quantification of proteins. Adv Protein Chem Struct Biol 80:1-44
53. Deutsch EW, Mendoza L, Shteynberg D, Farrah T, Lam H, Tasman N, Sun Z, Nilsson E, Pratt B, Prazen B, Eng JK, Martin DB, Nesvizhskii AI, Aebersold R (2010) A guided tour of the Trans-Proteomic Pipeline. Proteomics 10(6):1150-1159
54. Cohen EP, Fish BL, Sharma M, Li XA, Moulder JE (2007) The role of the angiotensin II type-2 receptor in radiation nephropathy. Transl Res 150:106-115
55. Sharma M, Halligan BD, Wakim BT, Savin VJ et al (2010) The urine proteome for radiation biodosimetry: effect of total body versus local kidney irradiation. Health Phys 98(2):186-195
56. Sharma M, McCarthy ET, Sharma R, Fish BL et al (2006) Arachidonic acid metabolites mediate the radiation-induced increase in glomerular albumin permeability. Exp Biol Med (Maywood) 231:99-106
57. Konvalinka A, Scholey JW, Diamandis EP (2011) Searching for new biomarkers of renal diseases through proteomics. Clin Chem. doi:10.1373/ clinchem.2011.165969
58. Coca SG, Singanamala S, Parikh CR (2011) Chronic kidney disease after acute kidney injury: a systematic review and meta-analysis. Kidney Int. doi:10.1038/ki.2011.379
59. Bonventre JV (2007) Diagnosis of acute kidney injury: from classic parameters to new biomarkers. Contrib Nephrol 156:213-219
60. Honore PM, Joannes-Boyau O, Boer W (2007) The early biomarker of acute kidney injury: in search of the Holy Grail. Intensive Care Med 33:1866-1868
61. Devarajan P (2008) Proteomics for the investigation of acute kidney injury. Contrib Nephrol 160:1-16
62. Kalousova M, Zima T, Tesar V, Dusilova-Sulkova S, Skrha J (2005) Advanced glycoxidation end products in chronic diseases-clinical chemistry and genetic background. Mutat Res 579:37-46
63. Narita T, Sasaki H, Hosoba M, Miura T et al (2004) Parallel increase in urinary excretion rates of immunoglobulin G, ceruloplasmin, transferrin, and orosomucoid in normoalbuminuric type 2 diabetic patients. Diabetes Care 27:1176-1181
64. Horvath AJ, Forsyth SL, Coughlin PB (2004) Expression patterns of murine antichymotrypsin-like genes reflect evolutionary divergence at the Serpina3 locus. J Mol Evol 59:488-497
65. Suzuki Y, Yoshida K, Honda E, Sinohara H (1991) Molecular cloning and sequence analysis of cDNAs coding for guinea pig alpha 1-antiproteinases S and F and contrapsin. J Biol Chem 266:928-932
66. Burkle A (2001) Poly(APD-ribosyl)ation, a DNA damage-driven protein modification and regulator of genomic instability. Cancer Lett 163:1-5
67. Lakin ND, Jackson SP (1999) Regulation of p53 in response to DNA damage. Oncogene 18:7644-7655
68. Kriengsinyos W, Rafii M, Wykes LJ, Ball RO, Pencharz PB (2002) Long-term effects of histidine depletion on whole-body protein metabolism in healthy adults. J Nutr 132:3340-3348
69. Uchida K, Kawakishi S (1993) 2-Oxo-histidine as a novel biological marker for oxidatively modified proteins. FEBS Lett 332:208-210
70. Moulder JE (2002) Report on an interagency workshop on the radiobiology of nuclear terrorism. Radiat Res 158(1):118-124
71. Moulder JE, Medhora M (2011) Advances in mitigation of injuries from radiological terrorism or nuclear accidents. Defence Sci J 61(2):99-104
72. Pellmar TC, Rockwell S (2005) Priority list of research areas for radiological nuclear threat countermeasures. Radiat Res 163(1):115-123
73. Brown SL, Kolozsvary A, Liu J, Jenrow KA, Ryu S, Kim JH (2010) Antioxidant diet supplementation starting 24 hours after exposure reduces radiation lethality. Radiat Res 173(4):462-468
74. MacVittie TJ, Farese AM, Jackson W (2005) Defining the full therapeutic potential of recombinant growth factors in the post radiation-accident environment: the effect of supportive care plus administration of G-CSF. Health Phys 89(5):546-555
75. Epperly MW, Wang H, Jones JA, Dixon T, Montesinos CA, Greenberger JS (2011) Antioxidant-chemoprevention diet ameliorates late effects of total-body irradiation and supplements radioprotection by MnSOD-plasmid liposome administration. Radiat Res 175(6): 759-765
76. Ghosh SN, Zhang R, Fish BL, Semenenko VA, Li XA, Moulder JE et al (2009) Renin-angiotensin system suppression mitigates experimental radiation pneumonitis. Int J Radiat Oncol Biol Phys 75(5):1528-1536
77. Jenrow KA, Brown SL, Liu J, Kolozsvary A, Kim JH (2010) Ramipril mitigates radiation-induced impairment of neurogenesis in the rat dentate gyrus. Radiat Oncol 5(1):Article 6
78. Cohen EP, Bedi M, Irving AA, Jacobs ER, Tomic R, Klein JP et al (2012) Mitigation of late renal and pulmonary injury after hematopoietic stem cell transplantation. Int J Radiat Oncol Biol Phys 83(1):292-296
79. Moulder JE, Robbins MEC, Cohen EP, Hopewell JW, Ward WF (1998) Pharmacologic modification of radiation-induced late normal tissue injury. Cancer Treat Res 93:129-151
80. Bertho JM, Roy L, Souidi M, Benderitter M, Gueguen Y, Lataillade JJ et al (2008) New biological indicators to evaluate and monitor radiationinduced damage: an accident case report. Radiat Res 169(5):543-550